However, we found that knock-down of ER-α36 expression in the ER-positive breast cancer cells diminished the tumor-seeding efficiency of the breast cancer stem/progenitor cells and the genomic estrogen-signaling mediated by ER-α66 is attenuated in the ER-positive breast cancer stem/progenitor cells. This evidence concerns the gene ESR1 and breast cancer.